About Granata Bio
Granata Bio is a private company based in Duxbury, Massachusetts, incorporated in 2020 in Delaware. It has reported $23,859,226 raised in two offerings on Form D since November 2023. Its chief executive is Evan Sussman.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 19, 2024 | Dec 31, 2024 | $13,765,000of $14.9M target | 3 | $4.5M | EquityRule 506(b) | Form D ↗ |
| Oct 25, 2023 | Nov 6, 2023 | $10,094,226of $13.9M target | 10 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $23,859,226 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Granata Bio's Form D filed Dec 31, 2024.
ES
Evan Sussman
Chief Executive Officer and director
SF
Sarah Faranda
Executive officer and director
EH
Eduardo Hariton
Director
DP
David Paller
Executive officer and director
PT
Peter Turek
Director